New prospects for management and treatment of inoperable and recurrent skull base meningiomas
- PMID: 17624496
- DOI: 10.1007/s11060-007-9434-z
New prospects for management and treatment of inoperable and recurrent skull base meningiomas
Abstract
Skull base, including optic nerve, cavernous sinus, clival and foramen magnum tumors represent a major challenge for neurosurgeons and neuro-oncologists. Growth regulatory signaling pathways for these tumors are of increasing interest as potential targets for new chemotherapy. Those differentially activated in various grades of meningiomas are currently being identified as well. This article reviews some recent findings pathways that appear to regulate meningioma growth. Potential targets for novel therapies are also discussed.
Similar articles
-
Honored guest presentation: contemporary treatment of skull base meningiomas.Clin Neurosurg. 2000;46:554-74. Clin Neurosurg. 2000. PMID: 10944701 Review. No abstract available.
-
Diffuse midline skull base meningiomas: identification of a rare and aggressive subgroup of meningiomas.J Neurooncol. 2017 Jul;133(3):633-639. doi: 10.1007/s11060-017-2480-2. Epub 2017 May 23. J Neurooncol. 2017. PMID: 28536991
-
Adoptive transfer of genetically modified Wilms' tumor 1-specific T cells in a novel malignant skull base meningioma model.Neuro Oncol. 2013 Jun;15(6):747-58. doi: 10.1093/neuonc/not007. Epub 2013 Mar 3. Neuro Oncol. 2013. PMID: 23460320 Free PMC article.
-
Clear cell meningiomas: three case reports with genetic characterization and review of the literature.Neurosurgery. 2010 Sep;67(3):E870-1; discussion E871. doi: 10.1227/01.NEU.0000374857.06732.CD. Neurosurgery. 2010. PMID: 20683214 Review.
-
[Treatment of petroclival meningiomas: current state of the problem].Zh Vopr Neirokhir Im N N Burdenko. 2019;83(6):78-89. doi: 10.17116/neiro20198306178. Zh Vopr Neirokhir Im N N Burdenko. 2019. PMID: 32031171 Review. Russian.
Cited by
-
Light at the end of the tunnel: towards an effective drug therapy for surgery- and radiation-refractory meningioma.Neuro Oncol. 2015 Jan;17(1):7-8. doi: 10.1093/neuonc/nou315. Epub 2014 Nov 4. Neuro Oncol. 2015. PMID: 25378633 Free PMC article. No abstract available.
-
Imatinib mesylate treatment of recurrent meningiomas in preselected patients: a retrospective analysis.J Neurooncol. 2012 Sep;109(2):323-30. doi: 10.1007/s11060-012-0896-2. Epub 2012 May 20. J Neurooncol. 2012. PMID: 22610940
-
Medical therapies for meningiomas.J Neurooncol. 2010 Sep;99(3):365-78. doi: 10.1007/s11060-010-0349-8. Epub 2010 Sep 4. J Neurooncol. 2010. PMID: 20820875 Review.
-
Neuroanatomical insights into neuro-ophthalmic presentations of skull base meningiomas: Pathways to precision medicine - A meta-analysis.Surg Neurol Int. 2024 Jun 28;15:224. doi: 10.25259/SNI_421_2024. eCollection 2024. Surg Neurol Int. 2024. PMID: 38974542 Free PMC article. Review.
-
Management options for cavernous sinus meningiomas.J Neurooncol. 2009 May;92(3):307-16. doi: 10.1007/s11060-009-9824-5. Epub 2009 Apr 9. J Neurooncol. 2009. PMID: 19357958 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources